Prediction of chemotherapeutic response by technetium 99m-MIBI scintigraphy in breast carcinoma patients
- 15 July 2001
- Vol. 92 (2) , 232-239
- https://doi.org/10.1002/1097-0142(20010715)92:2<232::aid-cncr1314>3.0.co;2-g
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosisSeminars in Nuclear Medicine, 1999
- Dynamic imaging: scintimammographyEuropean Journal of Radiology, 1998
- Scintigraphic imaging of breast cancerNuclear Medicine Communications, 1997
- Docetaxel: a new defence in the management of breast cancerAnti-Cancer Drugs, 1995
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody.Proceedings of the National Academy of Sciences, 1992
- Physiological basis of myocardial perfusion imaging with the technetium 99m agentsSeminars in Nuclear Medicine, 1991
- Isolation and expression of a complementary DNA that confers multidrug resistanceNature, 1986
- Human Multidrug-Resistant Cell Lines: Increased mdr 1 Expression Can Precede Gene AmplificationScience, 1986
- Genetic and biochemical characterization of multidrug resistancePharmacology & Therapeutics, 1985